News Releases

News Releases

Metacrine Raises $36 Million in Series A Financing
Appoints Neil McDonnell, CEO, Along with Executive Team and Board San Diego, CA – Metacrine, Inc., a biotechnology company focused on targeting metabolic disease through advances in endocrine research, today announced it has raised $36 million in a Series A financing.
Aug 5, 2015
Displaying 31 - 31 of 31